We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

150 hedge funds and large institutions have $1.97B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 32 increasing their positions, 55 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

245% more call options, than puts

Call options by funds: $124M | Put options by funds: $35.8M

56% more capital invested

Capital invested by funds: $1.27B → $1.97B (+$705M)

33% more funds holding in top 10

Funds holding in top 10: 68 (+2)

3% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 38

1% less funds holding

Funds holding: 152150 (-2)

42% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 55

Holders
150
Holders Change
-2
Holders Change %
-1.32%
% of All Funds
4.35%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.23%
New
37
Increased
32
Reduced
55
Closed
38
Calls
$124M
Puts
$35.8M
Net Calls
+$87.8M
Net Calls Change
-$92.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$4.84M +$618K +29,149 +22%
DCM
52
Driehaus Capital Management
Illinois
$4.75M +$3.37M +158,972 New
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$4.73M
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$4.7M +$218K +10,300 +7%
OAC
55
OMERS Administration Corp
Ontario, Canada
$4.48M +$3.18M +150,200 New
ECP
56
Elk Creek Partners
Colorado
$4.28M -$750K -35,373 -20%
BIM
57
BlackRock Investment Management
Delaware
$4.12M +$3.84K +181 +0.1%
Charles Schwab
58
Charles Schwab
California
$4M +$59.2K +2,793 +2%
JP Morgan Chase
59
JP Morgan Chase
New York
$4M -$1.17M -55,248 -29%
M&T Bank
60
M&T Bank
New York
$3.88M +$2.38M +112,086 +626%
CC
61
Carlson Capital
Texas
$3.88M +$2.76M +130,000 New
CPM
62
Chesapeake Partners Management
Maryland
$3.73M +$2.65M +125,000 New
WA
63
Whitebox Advisors
Minnesota
$3.7M +$2.63M +124,099 New
LCS
64
Levin Capital Strategies
New York
$3.43M -$1.69M -79,646 -41%
SO
65
STRS Ohio
Ohio
$3.28M
RCAMU
66
Rothschild & Co Asset Management US
Connecticut
$3.21M -$155K -7,320 -6%
TAM
67
Tocqueville Asset Management
New York
$3.13M -$969K -45,725 -30%
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
$3.11M -$819K -38,640 -27%
MCM
69
Moore Capital Management
New York
$2.98M -$1.06M -50,000 -33%
BA
70
BlackRock Advisors
Delaware
$2.85M +$1.41M +66,633 +230%
TA
71
Teachers Advisors
New York
$2.85M +$147K +6,944 +8%
USAA
72
United Services Automobile Association
Texas
$2.81M
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
$2.77M +$21.8K +1,027 +1%
AllianceBernstein
74
AllianceBernstein
Tennessee
$2.66M -$1.43M -67,340 -43%
JGC
75
J. Goldman & Co
New York
$2.62M +$1.6M +75,545 +613%

AUXL Hedge Fund Activity: Q3 2014 in Review

150 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q3 2014, worth a combined $1.97B — up 56% from $1.27B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of AUXL and 37 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 32 added.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $59.3M. The largest seller was TAMRO Capital Partners, exiting entirely with an estimated $37.9M sold.

  • 150 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q3 2014, down from 152 in Q2 2014.
  • Funds reported $1.97B of AUXILIUM PHARAMCEUTICALS INC stock for Q3 2014, up 56% quarter-over-quarter.
  • 37 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q3 2014 and 38 closed out, a net change of -1 holder.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q3 2014 was TIG Advisors LLC, an estimated $59.3M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q3 2014 was TAMRO Capital Partners, an estimated $37.9M sold.

Based on aggregated 13F filings for Q3 2014.